Duricef
Formulated to address bacterial infection to alleviate symptoms and support recovery from infections.
- Category
- Antibiotics
- Active ingredient
- Cefadroxil
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Tablet
- Strengths
- 250 · 500mg
Duricef details
- Conditions
- Bacterial Infection · Bacterial Pharyngitis
- Alternative names
- Baxan
- Therapeutic class
- First-Generation Cephalosporin Antibiotic
- Pharmacological class
- Cephalosporin Antibiotic
- Contraindications
- hypersensitivity to cephalosporins
- Minor side effects
- nausea; diarrhoea
- Moderate side effects
- elevated liver enzymes
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Bristol-Myers Squibb
- Onset Time
- 1–2 hours
- Duration
- 12–24 hours
- Storage instructions
- Store in a cool, dry place away from direct sunlight.
- Drug interactions
- probenecid
- Age restrictions
- Use requires clinical assessment across all age groups.
Precautions and warnings
monitor for signs of superinfection; use with caution in patients with history of gastrointestinal disease
Serious side effects
anaphylaxis, requires immediate medical attention; clostridioides difficile-associated diarrhoea, requires immediate medical attention
Patient summary
Formulated to address bacterial infection to alleviate symptoms and support recovery from infections.
Mechanism of action
Cefadroxil is a bactericidal antibiotic that acts by interfering with bacterial cell wall synthesis. It binds to essential penicillin-binding proteins, preventing the cross-linking of peptidoglycan chains, which leads to cell lysis and death of the susceptible bacteria.
Pregnancy and breastfeeding
Pregnancy: Use only if clearly needed. Breastfeeding: Use with caution as cefadroxil is excreted in breast milk.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Duricef
Duricef is a well-established brand containing cefadroxil, an active ingredient typically used for bacterial infection and bacterial pharyngitis. The medication is also sold under other brand names such as Baxan and is supplied as a tablet in 250mg and 500mg strengths. Manufactured by Bristol-Myers Squibb, this treatment provides a standard approach for managing specific bacterial conditions.
Duricef availability in Asia
Duricef is registered across 14 markets including Singapore, Hong Kong and Thailand, with availability also in Malaysia, the Philippines and Indonesia. Generic cefadroxil, much of it made in India, is often more affordable than the original brand, providing an accessible option for expats or those living far from a well-stocked pharmacy. This medicine is best used under a doctor’s care.